Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01792050
Title Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors NewLink Genetics Corporation
Indications

Her2-receptor negative breast cancer

Therapies

Docetaxel

Indoximod

Paclitaxel

Age Groups: adult
Covered Countries USA


No variant requirements are available.